Pay in 4 interest-free payments of $5.86 Learn more
Ships within 48 hours · Estimated delivery Oct 11 - Oct 16
First-line therapy for type 2 diabetes with sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists: a cost-effectiveness study
Geopolitical factorstrade policies, sanctions, export controls on dual-use chemical equipmentcan alter lead times and compliance costs
Due to their high biocompatibility and strong bioactivity, sEVs act as a promising tool for therapeutic delivery strategies in cancer therapy
Published in November 2020
Targeted therapy would deliver glutathione to targeted tissues for better results
US$ 27.21
US$ 21.49
US$ 22.62
US$ 26.78
US$ 23.64
US$ 22.24
US$ 29.34
US$ 27.47
US$ 28.92
US$ 22.68
US$ 25.17
US$ 27.50
US$ 24.43
US$ 20.98
US$ 28.76
US$ 21.72
